Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | IGF1R | P08069 | 3/20 | 0.46 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.46 |
| ▸ | KDR | P35968 | 2/20 | 0.46 |
| ▸ | SUMO3 | P55854 | 1/20 | 0.42 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1019383 | 0.81 | IP6K1 (0.47) | HDAC3HDAC1HDAC2HDAC6KDM4E | |
| SCHEMBL6343838 | 0.77 | SMN1; SMN2 (0.50) | KDM4EHTTNPC1RAB9AHPGD | |
| SCHEMBL4551624 | 0.77 | FLT3 (0.44) | NPC1RAB9AHPGDSMN1; SMN2KDR | |
| SCHEMBL30939422 | 0.76 | RAD52 (0.39) | KDM4EHTTRAB9AHPGDSMN1; SMN2 | |
| SCHEMBL21303621 | 0.76 | MAOA (0.54) | RECQLMAOAMAOBHDAC3HDAC1 | |
| SCHEMBL15690 | 0.73 | SMN1; SMN2 (0.49) | KDM4EHTTNPC1RAB9ATP53 | |
| SCHEMBL4411497 | 0.73 | SMN1; SMN2 (0.49) | HDAC3HDAC1HDAC2HDAC6KDM4E | |
| SCHEMBL1244338 | 0.72 | MAOA (0.70) | MAOAMAOBHDAC3HDAC1HDAC2 | |
| SCHEMBL28147882 | 0.72 | MAOA (0.51) | MAOAMAOBHDAC3HDAC1HDAC2 | |
| SCHEMBL22191119 | 0.72 | HDAC3 (0.60) | MAOAMAOBHDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116975-A1 | ADENOSINE A3 RECEPTOR AGONISTS, PREPARATION METHODS AND USES THEREOF | ZHEJIANG VIMGREEN PHARMACEUTICALS, LTD. (CN) | 2024-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116975-A1 | ADENOSINE A3 RECEPTOR AGONISTS, PREPARATION METHODS AND USES THEREOF | ADORA3, ADORA2A, ADORA2B | RECQL 1078/4885MAOA 316/4885MAOB 360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.